Calcimimetic agents for the treatment of hyperparathyroidism

被引:14
作者
Goodman, WG [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr,Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/00041552-200109000-00005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Calcimimetic agents are small organic molecules that act as allosteric activators of the calcium sensing receptor. They lower the threshold for receptor activation by extracellular calcium ions and, in parathyroid cells, diminish parathyroid hormone secretion. Calcimimetic compounds represent a novel class of therapeutic agents that may provide a way of controlling excess parathyroid hormone secretion in several clinical disorders. Although experience from clinical trials in humans is limited, available data suggest that calcimimetic agents effectively lower plasma parathyroid hormone levels in patients with primary hyperparathyroidism and those with secondary hyperparathyroidism caused by end-stage renal disease. Calcimimetic compounds thus have considerable potential as a new approach to the medical management of several important clinical disorders of bone and mineral metabolism. Curr Opin Nephrol Hypertens 10:575-580. (C), 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:575 / 580
页数:6
相关论文
共 44 条
[1]   A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure -: Rapid communication [J].
Antonsen, JE ;
Sherrard, DJ ;
Andress, DL .
KIDNEY INTERNATIONAL, 1998, 53 (01) :223-227
[2]   Protein kinase C phosphorylation of threonine at position 888 in Ca2+0-sensing receptor (CaR) inhibits coupling to Ca2+ store release [J].
Bai, M ;
Trivedi, S ;
Lane, CR ;
Yang, YH ;
Quinn, SJ ;
Brown, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :21267-21275
[3]   Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function [J].
Bai, M ;
Trivedi, S ;
Kifor, O ;
Quinn, SJ ;
Brown, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :2834-2839
[4]   Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells [J].
Bai, M ;
Trivedi, S ;
Brown, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23605-23610
[5]   The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain [J].
Bräuner-Osborne, H ;
Jensen, AA ;
Sheppard, PO ;
O'Hara, P ;
Krogsgaard-Larsen, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18382-18386
[6]   4-PARAMETER MODEL OF THE SIGMOIDAL RELATIONSHIP BETWEEN PARATHYROID-HORMONE RELEASE AND EXTRACELLULAR CALCIUM-CONCENTRATION IN NORMAL AND ABNORMAL PARATHYROID TISSUE [J].
BROWN, EM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (03) :572-581
[7]   CLONING AND CHARACTERIZATION OF AN EXTRACELLULAR CA2+-SENSING RECEPTOR FROM BOVINE PARATHYROID [J].
BROWN, EM ;
GAMBA, G ;
RICCARDI, D ;
LOMBARDI, M ;
BUTTERS, R ;
KIFOR, O ;
SUN, A ;
HEDIGER, MA ;
LYTTON, J ;
HEBERT, SC .
NATURE, 1993, 366 (6455) :575-580
[8]   Extracellular calcium sensing and extracellular calcium signaling [J].
Brown, EM ;
MacLeod, RJ .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :239-297
[9]  
Chin J, 2000, J AM SOC NEPHROL, V11, P903, DOI 10.1681/ASN.V115903
[10]   A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations [J].
Cole, DEC ;
Peltekova, VD ;
Rubin, LA ;
Hawker, GA ;
Vieth, R ;
Liew, CC ;
Hwang, DM ;
Evrovski, J ;
Hendy, GN .
LANCET, 1999, 353 (9147) :112-115